Buckingham Capital Management (New York)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-223,796
| Closed | -$8.38M | – | 84 |
|
|
2016
Q1 | $8.38M | Buy |
223,796
+41,487
| +23% | +$1.55M | 0.95% | 41 |
|
|
2015
Q4 | $7.87M | Sell |
182,309
-7,703
| -4% | -$332K | 0.97% | 45 |
|
|
2015
Q3 | $7.12M | Buy |
190,012
+15,636
| +9% | +$586K | 0.64% | 65 |
|
|
2015
Q2 | $5.93M | Sell |
174,376
-594
| -0.3% | -$20.2K | 0.49% | 72 |
|
|
2015
Q1 | $6.19M | Buy |
+174,970
| New | +$6.19M | 0.54% | 69 |
|